These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 9871709)

  • 1. The synthesis and evaluation of benzannelated-azatoxins: the benzazatoxins.
    Miller TA; Vachaspati PR; Labroli MA; Thompson CD; Bulman AL; Macdonald TL
    Bioorg Med Chem Lett; 1998 May; 8(9):1065-70. PubMed ID: 9871709
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of DNA topoisomerase II by azaelliptitoxins functionalized in the variable substituent domain.
    Tepe JJ; Madalengoitia JS; Slunt KM; Werbovetz KW; Spoors PG; Macdonald TL
    J Med Chem; 1996 May; 39(11):2188-96. PubMed ID: 8667362
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cellular pharmacology of azatoxins (topoisomerase-II and tubulin inhibitors) in P-glycoprotein-positive and -negative cell lines.
    Eymin B; Solary E; Chevillard S; Dubrez L; Goldwasser F; Duchamp O; Genne P; Leteurtre F; Pommier Y
    Int J Cancer; 1995 Oct; 63(2):268-75. PubMed ID: 7591216
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tyrphostins. 5. Potent inhibitors of platelet-derived growth factor receptor tyrosine kinase: structure-activity relationships in quinoxalines, quinolines, and indole tyrphostins.
    Gazit A; App H; McMahon G; Chen J; Levitzki A; Bohmer FD
    J Med Chem; 1996 May; 39(11):2170-7. PubMed ID: 8667360
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and inhibitory activity of novel tri- and tetracyclic quinolines against topoisomerases.
    Sui Z; Altom J; Nguyen VN; Fernandez J; Bernstein JI; Hiliard JJ; Barrett JF; Podlogar BL; Ohemeng KA
    Bioorg Med Chem; 1998 Jun; 6(6):735-42. PubMed ID: 9681139
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dual inhibition of topoisomerase II and tubulin polymerization by azatoxin, a novel cytotoxic agent.
    Solary E; Leteurtre F; Paull KD; Scudiero D; Hamel E; Pommier Y
    Biochem Pharmacol; 1993 Jun; 45(12):2449-56. PubMed ID: 8392342
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and cytotoxicity of indolopyrrolemaleimides.
    Xu GQ; Guo P; Zhang C; He QJ; Yang B; Hu YZ
    Chem Pharm Bull (Tokyo); 2007 Sep; 55(9):1302-7. PubMed ID: 17827752
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and biological evaluation of novel 2-arylamino-3-(arylsulfonyl)quinoxalines as PI3Kα inhibitors.
    Wu P; Su Y; Liu X; Zhang L; Ye Y; Xu J; Weng S; Li Y; Liu T; Huang S; Yang B; He Q; Hu Y
    Eur J Med Chem; 2011 Nov; 46(11):5540-8. PubMed ID: 21945250
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Azatoxin is a mechanistic hybrid of the topoisomerase II-targeted anticancer drugs etoposide and ellipticine.
    Cline SD; Macdonald TL; Osheroff N
    Biochemistry; 1997 Oct; 36(42):13095-101. PubMed ID: 9335572
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Azatoxin derivatives with potent and selective action on topoisomerase II.
    Leteurtre F; Sackett DL; Madalengoitia J; Kohlhagen G; MacDonald T; Hamel E; Paull KD; Pommier Y
    Biochem Pharmacol; 1995 May; 49(9):1283-90. PubMed ID: 7763310
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and biological activity of 7H-benzo[4,5]indolo[2,3-b]-quinoxaline derivatives.
    Shibinskaya MO; Karpenko AS; Lyakhov SA; Andronati SA; Zholobak NM; Spivak NY; Samochina NA; Shafran LM; Zubritsky MJ; Galat VF
    Eur J Med Chem; 2011 Feb; 46(2):794-8. PubMed ID: 21172726
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antitumor agents. Part 186: Synthesis and biological evaluation of demethylcolchiceinamide analogues as cytotoxic DNA topoisomerase II inhibitors.
    Guan J; Zhu XK; Tachibana Y; Bastow KF; Brossi A; Hamel E; Lee KH
    Bioorg Med Chem; 1998 Nov; 6(11):2127-31. PubMed ID: 9881102
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis of Thymidine Phosphorylase Inhibitor Based on Quinoxaline Derivatives and Their Molecular Docking Study.
    Almandil NB; Taha M; Farooq RK; Alhibshi A; Ibrahim M; Anouar EH; Gollapalli M; Rahim F; Nawaz M; Shah SAA; Ahmed QU; Zakaria ZA
    Molecules; 2019 Mar; 24(6):. PubMed ID: 30871147
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel indole inhibitors of IMPDH from fragments: synthesis and initial structure-activity relationships.
    Beevers RE; Buckley GM; Davies N; Fraser JL; Galvin FC; Hannah DR; Haughan AF; Jenkins K; Mack SR; Pitt WR; Ratcliffe AJ; Richard MD; Sabin V; Sharpe A; Williams SC
    Bioorg Med Chem Lett; 2006 May; 16(9):2539-42. PubMed ID: 16483773
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and SAR of novel imidazoquinoxaline-based Lck inhibitors: improvement of cell potency.
    Chen P; Iwanowicz EJ; Norris D; Gu HH; Lin J; Moquin RV; Das J; Wityak J; Spergel SH; de Fex H; Pang S; Pitt S; Shen DR; Schieven GL; Barrish JC
    Bioorg Med Chem Lett; 2002 Nov; 12(21):3153-6. PubMed ID: 12372522
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and antifungal activities of novel 5,6-dihydro-indolo[1,2-a]quinoxaline derivatives.
    Xu H; Fan LL
    Eur J Med Chem; 2011 May; 46(5):1919-25. PubMed ID: 21388718
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and evaluation of quinoxaline derivatives as potential influenza NS1A protein inhibitors.
    You L; Cho EJ; Leavitt J; Ma LC; Montelione GT; Anslyn EV; Krug RM; Ellington A; Robertus JD
    Bioorg Med Chem Lett; 2011 May; 21(10):3007-11. PubMed ID: 21478016
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 1,2,3-triazole tethered Indole-3-glyoxamide derivatives as multiple inhibitors of 5-LOX, COX-2 & tubulin: Their anti-proliferative & anti-inflammatory activity.
    Naaz F; Preeti Pallavi MC; Shafi S; Mulakayala N; Shahar Yar M; Sampath Kumar HM
    Bioorg Chem; 2018 Dec; 81():1-20. PubMed ID: 30081353
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low molecular weight indole fragments as IMPDH inhibitors.
    Beevers RE; Buckley GM; Davies N; Fraser JL; Galvin FC; Hannah DR; Haughan AF; Jenkins K; Mack SR; Pitt WR; Ratcliffe AJ; Richard MD; Sabin V; Sharpe A; Williams SC
    Bioorg Med Chem Lett; 2006 May; 16(9):2535-8. PubMed ID: 16483769
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and peptidyl-prolyl isomerase inhibitory activity of quinoxalines as ligands of cyclophilin A.
    Wang F; Chen J; Liu X; Shen X; He X; Jiang H; Bai D
    Chem Pharm Bull (Tokyo); 2006 Mar; 54(3):372-6. PubMed ID: 16508195
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.